Evidence map›Paper›PMID 31915304›Full record

ArticleScience translational medicine2020

HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.

Markus Wallner, Deborah M Eaton, Remus M Berretta, Laura Liesinger, Matthias Schittmayer, Juergen Gindlhuber, Jichuan Wu, Mark Y Jeong, Ying H Lin, Giulia Borghetti and 14 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Epigenetic Mechanisms in Heart Diseases.Reviews in cardiovascular medicine · 2025
    Review
  9. Article
  10. Sexual dimorphism in animal models of heart failure with preserved ejection fraction.Journal of applied physiology (Bethesda, Md. : 1985) · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Using Omics to Identify Novel Therapeutic Targets in Heart Failure.Circulation. Genomic and precision medicine · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Markus WallnerCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0001-7692-892X
Deborah M EatonCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0002-6913-7668
Remus M BerrettaCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Laura LiesingerMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.
Matthias SchittmayerMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0003-3249-655X
Juergen GindlhuberMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0002-6155-5208
Jichuan WuCENTRe: Consortium for Environmental and Neonatal Therapeutics Research, Lewis Katz School of Medicine, Department of Physiology, Department of Thoracic Medicine and Surgery, Pediatrics, Center for Inflammation, Translational and Clinical Lung Research, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0003-0068-5049
Mark Y JeongDepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Ying H LinDepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-3285-8787
Giulia BorghettiCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Sandy T BakerCENTRe: Consortium for Environmental and Neonatal Therapeutics Research, Lewis Katz School of Medicine, Department of Physiology, Department of Thoracic Medicine and Surgery, Pediatrics, Center for Inflammation, Translational and Clinical Lung Research, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0002-0554-8222
Huaqing ZhaoDepartment of Clinical Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Jessica PflegerCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0003-3263-035X
Sandra BlassMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.
Peter P RainerDivision of Cardiology, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0002-2840-6454
Dirk von LewinskiDivision of Cardiology, Medical University of Graz, Graz 8036, Austria.
Heiko BuggerDivision of Cardiology, Medical University of Graz, Graz 8036, Austria.
Sadia MohsinCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Wolfgang F GraierMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0003-1871-3298
Andreas ZirlikDivision of Cardiology, Medical University of Graz, Graz 8036, Austria.
Timothy A McKinseyDepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0001-7778-4470
Ruth Birner-GruenbergerMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0003-3950-0312
Marla R WolfsonCENTRe: Consortium for Environmental and Neonatal Therapeutics Research, Lewis Katz School of Medicine, Department of Physiology, Department of Thoracic Medicine and Surgery, Pediatrics, Center for Inflammation, Translational and Clinical Lung Research, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0003-4122-1769
Steven R HouserCardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. srhouser@temple.edu.ORCID 0000-0001-6359-5425
Medical University of Graz · ATTemple University · USUniversity of Colorado Anschutz Medical Campus · USTU Wien · AT

Funding

Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.R01HL127240 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY, SRIVASTAVA, DEEPAK · 2015 to 2022
$6.4M
Calcium and Cardiac Regeneration after Myocardial InfarctionR01HL033921 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI HOUSER, STEVEN R · 1985 to 2017
$5.6M
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEFR01HL147558 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HOUSER, STEVEN R, MCKINSEY, TIMOTHY · 2019 to 2022
$3.1M
Regulation of Cardiac Signaling by Class I Histone DeacetylasesR01HL116848 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY · 2013 to 2021
$3.1M
Colorado Clinical and Translational Sciences InstituteKL2TR001080 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$2.6M
Ca2+ Regulation in Newly Formed Ventricular MyocytesR37HL033921 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI HOUSER, STEVEN R · 2009 to 2013
$2.2M
Paracrine Modulation of Cardiac Repair processes by Cortical Bone Derived Stem CellsR01HL137850 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI MOHSIN, SADIA · 2018 to 2021
$1.6M
Paracrine Modulation of Cardiac Repairprocesses by Cortical Bone Derived Stem CellsR56HL137850 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI MOHSIN, SADIA · 2017 to 2017
$396k
Austrian Science Fund FWF W 1226NCATS NIH HHS KL2 TR001080NHLBI NIH HHS R01 HL033921NHLBI NIH HHS R01 HL116848NHLBI NIH HHS R01 HL127240NHLBI NIH HHS R01 HL137850NHLBI NIH HHS R01 HL147558NHLBI NIH HHS R37 HL033921NHLBI NIH HHS R56 HL137850
6 · The paper itself

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a major health problem without effective therapies. This study assessed the effects of histone deacetylase (HDAC) inhibition on cardiopulmonary structure, function, and metabolism in a large mammalian model of pressure overload recapitulating features of diastolic dysfunction common to human HFpEF. Male domestic short-hair felines (

Indexed as

DiastoleAnimalsBlood PressureCatsDisease Models, AnimalHeart FailureHeart VentriclesHistone Deacetylase InhibitorsLungMaleMitochondriaMuscle Fibers, SkeletalMyocytes, CardiacMyofibrilsPhenotypeProtein Processing, Post-TranslationalHistone Deacetylase InhibitorsVorinostat

Identifiers

PMID31915304
PMCPMC7065257
OpenAlexW2999564395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.